Research article · 30 Jul 2021
Review articlePublished 2012
Novel Technologies and Future Perspectives of Drug-Eluting Stent
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As compared with bare metal stents (BMS), Drug-eluting stents (DES) have dramatically reduced the incidence of target lesion revascularization and neointimal formation. There are, however, potential toxic effects of DES upon arterial tissue. Previous pathological studies have indicated that durable polymers and the drug itself play critical role in delayed endothelialization, persistent inflammation, hypersensitivity, apoptosis, necrosis, and positive remodeling leading to adverse cardiovascular events. To address these issues, new generation DES, biodegradable polymers, polymer-free and fully bioabsorbable scaffolds are currently in evolution. This review summarized the clinical trials that have assessed the feasibility and efficacy of new generation DES. A number of pivotal trials have also demonstrated the non-inferiority of biodegradable polymer or polymer-free DES to durable polymer DES in terms of clinical outcomes and angiographic in-stent late loss, although long-term follow-up data remain sparse. Fully absorbable DES has also provided promising results in selected populations and requires sufficiently powered randomized studies to assess their safety and efficacy.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2013
High SYNTAX Score and Long-Term Outcome Following Percutaneous Coronary Intervention with Drug-Eluting Stents: Insights from the LEADERS Trial
Editorial · 2012
Optical Coherence Tomography in the Era of Drug-Eluting Stents: An Indispensable Workhorse
Editorial · 2012
Drug-Eluting Stents in Interventional Cardiology
Editorial · 2011
The Drama of Drug-eluting Stent Thrombosis: Dr. Jekyll and Mr. Hyde
More from this journal
The newest in Translational Medicine.
Opinion · 25 Jun 2026
Radiomics in Translational Medicine for Quantitative Imaging and Personalized Clinical Assessment
Opinion · 25 Jun 2026
Digital Twin Technology in Translational Medicine for Individualized Disease Simulation and Clinical Planning
Opinion · 25 Jun 2026
Proteomic Signatures in Translational Medicine for Disease Stratification and Therapeutic Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Kohei Wakabayashi”
- BylineArticles whose byline prints “Rajbabu Pakala”
- BylineArticles whose byline prints “Michael Mahmoudi”
- BylineArticles whose byline prints “Takuya Watanabe”
- BylineArticles whose byline prints “Hiroyoshi Mori”
- BylineArticles whose byline prints “Yoshitaka Iso”
- BylineArticles whose byline prints “Hiroshi Suzuki”

